Immediate Impact
62 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Cancer immune evasion, immunoediting and intratumour heterogeneity
2025 Standout
Works of Timothy T. Spear being referenced
How an alloreactive T-cell receptor achieves peptide and MHC specificity
2017
Strategies to genetically engineer T cells for cancer immunotherapy
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Timothy T. Spear | 189 | 235 | 57 | 107 | 18 | 343 | |
| Nicholas J. Pumphrey | 201 | 288 | 31 | 117 | 15 | 407 | |
| Zoya Alteber | 256 | 257 | 57 | 79 | 12 | 368 | |
| Hua Tao | 129 | 168 | 26 | 108 | 15 | 311 | |
| Nathaniel Liddy | 247 | 313 | 51 | 95 | 11 | 388 | |
| Carlos Luri‐Rey | 185 | 201 | 30 | 88 | 21 | 301 | |
| Nishant K. Singh | 182 | 234 | 29 | 171 | 15 | 372 | |
| Kazuko Tsuneoka | 94 | 173 | 37 | 130 | 27 | 385 | |
| Katrin Birkholz | 223 | 184 | 85 | 150 | 18 | 358 | |
| Ron S. Gejman | 300 | 249 | 26 | 123 | 11 | 395 | |
| Frederick Arce Vargas | 192 | 199 | 34 | 174 | 11 | 371 |
All Works
Login with ORCID to disown or claim papers
Loading papers...